Zalunfiban, a glycoprotein IIb/IIIa inhibitor specifically formulated for rapid subcutaneous administration, has been ...
Zalunfiban, a prehospital platelet inhibitor given by injection at the point of first medical contact for suspected STEMI, ...
11 天on MSN
UP healthcare revamp: Ayushman Bharat, STEMI care & private hospitals transform state’s ...
Uttar Pradesh has significantly enhanced its healthcare infrastructure and service delivery, focusing on disease control, ...
A study was conducted to examine the predictive performance of an AI ECG algorithm for identifying occlusive myocardial infarction.
The drug, delivered by EMS as a single injection, improved infarct-related patency at cath lab arrival and 30-day clinical outcomes.
Physicians will remain in the loop, but AI can “turbocharge and augment our abilities,” an emergency medicine physician says.
Patients receiving oral niacinamide for nonmelanoma skin cancer chemoprophylaxis show fewer cardiac events, a retrospective ...
MedPage Today on MSN
Rapid-Acting Drug for Major Heart Attacks Hits Main Goal in Trial
NEW ORLEANS -- Patients experiencing major heart attacks had a lower risk of serious complications if they received a single ...
MedPage Today on MSN
STEMI Outcomes Not Helped by Upfront Instantaneous Wave-Free Ratio, Multivessel PCI
Of note, the iMODERN trial had also excluded people with a history of prior STEMI, chronic total occlusion, complex non-culprit lesions, left main disease, and those hemodynamically unstable or left ...
Background Primary percutaneous coronary intervention (PCI) has significantly improved outcomes for ST-segment elevation ...
Intracoronary infusion of mesenchymal stem cells reduces the risk for heart failure and heart failure readmission among ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果